Skip to main content
Premium Trial:

Request an Annual Quote

Element Biosciences: Jeff Journey, David Melaugh, Jeff Labbadia

Element Biosciences, a San Diego startup developing next-generation sequencing technologies, has made several appointments to its management team.

Jeff Journey has been named the firm's chief commercial officer. Most recently, he was VP and general manager at Thermo Fisher Scientific, where he oversaw the sample preparation business unit. Prior to that, he held various marketing, sales, service and support, and strategy roles at Thermo Fisher, Johnson & Johnson, and General Electric. He is also a veteran of the US Air Force.

David Melaugh has been appointed as general counsel. He joins Element from Apple, where he was senior director of the worldwide intellectual property litigation team. Prior to that, he was a partner at Morrison & Foerster.

Jeff Labbadia has joined Element as VP of operations. Previously, he spent 22 years at Becton Dickinson, where he held various global operations leadership roles.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.